METTL14 and amyotrophic lateral sclerosis: In our proposed model (depicted in Supplementary Fig. 14b), we postulate that the aberrant down-regulation of the two m6A methyltransferases, namely METTL3 and METTL14, in ALS reflects an anomaly likely associated with the natural aging process compounded by unidentified exacerbating factors29.